STERIS (STE) Director Cynthia L. Feldmann Receives Awards

What Happened
Cynthia L. Feldmann, a director of STERIS plc (STE), was granted two awards on August 10, 2026: 1,506 nonqualified stock options and 512 Career Restricted Stock Units (RSUs). The Form 4 reports acquisition price as $0 for both items (award grants), meaning no cash was paid at grant. The options are reported as fully vested and exercisable immediately; the Career RSUs are fully vested but will settle in ordinary shares six months after the director ceases Board service.

Key Details

• Transaction date: 2026-08-10; Form 4 filed 2026-08-12 (appears timely).
• Awards: 1,506 nonqualified stock options (derivative, reported at $0) and 512 Career RSUs (reported at $0).
• Shares owned after transaction: not specified in the provided filing data.
• Footnotes:
  • F1 — the nonqualified stock options are fully vested and exercisable immediately.
  • F2/F3 — each Career RSU equals the right to one STERIS share; RSUs are fully vested now but will be settled in shares six months after cessation of Board service.
• Transaction code: A = Award/Grant (not a purchase or sale).

Context
These entries are compensatory awards to a director (common for board remuneration) rather than open-market purchases or sales, so they do not directly signal a cash investment by the insider. The options being immediately exercisable means Feldmann can convert them to shares subject to any exercise price and applicable holding/insider trading rules; the Career RSUs are deferred settlement awards tied to future cessation of board service.